Stonepine Capital Management
QNRX icon

Stonepine Capital Management’s Quoin Pharmaceuticals QNRX Stock Holding History

Stonepine Capital Management’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.15M Buy
252,434
+52,948
+27% +$285K 0.72% 35
2026
Q2 		$966K Buy
199,486
+146,026
+273% +$788K 0.54% 44
2026
Q1 		$353K Sell
53,460
-24,729
-32% -$224K 0.14% 61
2025
Q4 		$1.13M Buy
+78,189
New +$1.06M 0.82% 33

Other funds holding QNRX

ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $140M AUM 44.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Arax Advisory Partners
Arax Advisory Partners Denver, Colorado $17.7B AUM 20.22% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Stonepine Capital Management's QNRX Position: Q3 2026 in Review

Stonepine Capital Management increased its Quoin Pharmaceuticals (QNRX) stake by 27% in Q3 2026, buying an estimated $285K and bringing the position to 252,434 shares worth $1.15M. The position accounts for 0.72% of the portfolio, ranked #35.

Stonepine Capital Management first reported a position in QNRX in Q4 2025 and has held it in 4 quarters since. 13 funds tracked by Wall St. Rank hold QNRX as of Q3 2026.

  • Stonepine Capital Management held 252,434 shares of Quoin Pharmaceuticals worth $1.15M as of Q3 2026.
  • Stonepine Capital Management bought 52,948 Quoin Pharmaceuticals shares in Q3 2026, an estimated $285K.
  • Quoin Pharmaceuticals made up 0.72% of Stonepine Capital Management's portfolio in Q3 2026, its #35 holding.
  • Stonepine Capital Management first reported a position in Quoin Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • 13 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q3 2026.

Based on Stonepine Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.